Advertisement
Advertisement
RMD
ResMed Inc.
224.46
USDSponsored
-2.28
-1.01%
Aug 14, 15:59 UTC -4
Closed
After-Market
223.41
-1.05
-0.47%
RMD Earnings Reports
Positive Surprise Ratio
RMD beat 29 of 42 last estimates.
69%
Next Report
Date of Next Report
Oct 28, 2026
Estimate for Q1 27 (Revenue/ EPS)
$1.38B
/$2.73
Implied change from Q4 26 (Revenue/ EPS)
-5.93%
/-7.46%
Implied change from Q1 26 (Revenue/ EPS)
+3.09%
/+7.48%
ResMed Inc. earnings per share and revenue
On Aug 06, 2026, RMD reported earnings of 2.95 USD per share (EPS) for Q4 26, beating the estimate of 2.91 USD, resulting in a 1.09% surprise. Revenue reached 1.46 billion, compared to an expected 1.47 billion, with a -0.70% difference. The market reacted with a -5.06% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 12 analysts forecast an EPS of 2.73 USD, with revenue projected to reach 1.38 billion USD, implying an decrease of -7.46% EPS, and decrease of -5.93% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.16
Actual
$0.20
Surprise
+24.07%
Omeros Corporation
Report Date
Aug 12, 2026 For Q2 26
Estimate
-$0.27
Actual
$0.02
Surprise
+107.31%
Varex Imaging Corporation Common Stock
Report Date
Aug 10, 2026 For Q3 26
Estimate
$0.21
Actual
$0.31
Surprise
+44.93%
Brainsway Ltd. - ADR
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.15
Actual
$0.14
Surprise
-7.65%
Valneva SE - ADR
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.34
Surprise
-243.33%
Village Farms International, Inc. Common Shares
Report Date
Aug 10, 2026 For Q2 26
Estimate
$0.02
Actual
$0.06
Surprise
+154.24%
Capricor Therapeutics Inc
Report Date
Aug 13, 2026 For Q2 26
Estimate
-$0.60
Actual
-$0.70
Surprise
-16.32%
Organigram Global Inc. Common Shares
Report Date
Aug 11, 2026 For Q3 26
Estimate
$0.00
Actual
-$0.06
Surprise
-2,480.74%
Immucell Corp
Report Date
Aug 13, 2026 For Q2 26
Estimate
-Actual
$0.20
Surprise
-
FitLife Brands, Inc. Common Stock
Report Date
Aug 13, 2026 For Q2 26
Estimate
$0.19
Actual
$0.20
Surprise
+0.55%
FAQ
What were ResMed Inc.'s earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, ResMed Inc. reported EPS of $2.95, beating estimates by 1.09%, and revenue of $1.46B, -0.7% below expectations.
How did the market react to ResMed Inc.'s Q4 2026 earnings?
The stock price moved down -5.06%, changed from $223.24 before the earnings release to $211.94 the day after.
When is ResMed Inc. expected to report next?
The next earning report is scheduled for Oct 28, 2026.
What are the forecasts for ResMed Inc.'s next earnings report?
Based on 12
analysts, ResMed Inc. is expected to report EPS of $2.73 and revenue of $1.38B for Q1 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement